OTCMKTS:CLPBY - COLOPLAST A/S/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $10.6050 -0.07 (-0.66 %) (As of 05/20/2019 12:51 PM ET)Previous Close$10.68Today's Range$10.56 - $10.6452-Week Range$8.90 - $11.15Volume1,932 shsAverage Volume68,642 shsMarket CapitalizationN/AP/E Ratio36.57Dividend Yield0.74%Beta0.54 ProfileChartDividendEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. It offers disposable products that include prostate catheters and stents used before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark. Receive CLPBY News and Ratings via Email Sign-up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CLPBY Previous SymbolNASDAQ:CLPBY CUSIPN/A CIKN/A Webwww.coloplast.com Phone45-4911-1111Debt Debt-to-Equity Ratio0.02 Current Ratio0.94 Quick Ratio0.65Price-To-Earnings Trailing P/E Ratio36.57 Forward P/E RatioN/A P/E Growth3.56 Sales & Book Value Annual Sales$2.63 billion Price / SalesN/A Cash Flow$0.3583 per share Price / Cash Flow29.60 Book Value$0.52 per share Price / Book20.39Profitability EPS (Most Recent Fiscal Year)$0.29 Net Income$614.43 million Net Margins23.28% Return on Equity71.14% Return on Assets32.75%Miscellaneous Employees11,738 Outstanding SharesN/AMarket CapN/A Next Earnings Date8/14/2019 (Estimated) OptionableNot Optionable COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Frequently Asked Questions What is COLOPLAST A/S/ADR's stock symbol? COLOPLAST A/S/ADR trades on the OTCMKTS under the ticker symbol "CLPBY." How often does COLOPLAST A/S/ADR pay dividends? What is the dividend yield for COLOPLAST A/S/ADR? COLOPLAST A/S/ADR announced a Semi-Annual dividend on Friday, April 5th. Shareholders of record on Tuesday, May 7th will be paid a dividend of $0.04 per share on Wednesday, May 22nd. The ex-dividend date of this dividend is Monday, May 6th. View COLOPLAST A/S/ADR's Dividend History. How were COLOPLAST A/S/ADR's earnings last quarter? COLOPLAST A/S/ADR (OTCMKTS:CLPBY) issued its quarterly earnings results on Thursday, May, 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.07. The firm had revenue of $688.45 million for the quarter. COLOPLAST A/S/ADR had a return on equity of 71.14% and a net margin of 23.28%. View COLOPLAST A/S/ADR's Earnings History. When is COLOPLAST A/S/ADR's next earnings date? COLOPLAST A/S/ADR is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for COLOPLAST A/S/ADR. Has COLOPLAST A/S/ADR been receiving favorable news coverage? Media coverage about CLPBY stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. COLOPLAST A/S/ADR earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. Who are some of COLOPLAST A/S/ADR's key competitors? Some companies that are related to COLOPLAST A/S/ADR include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX) and ConforMIS (CFMS). What other stocks do shareholders of COLOPLAST A/S/ADR own? Based on aggregate information from My MarketBeat watchlists, some companies that other COLOPLAST A/S/ADR investors own include Advanced Micro Devices (AMD), Broadcom (AVGO), Intuitive Surgical (ISRG), BOX (BOX), Citigroup (C), Delta Air Lines (DAL), Evolent Health (EVH), General Electric (GE), Regions Financial (RF) and FANUC LTD JAPAN/ADR (FANUY). Who are COLOPLAST A/S/ADR's key executives? COLOPLAST A/S/ADR's management team includes the folowing people: Mr. Kristian Villumsen, Pres & CEO (Age 49)Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (Age 47)Mr. Allan Rasmussen, Exec. VP of Global Operations (Age 52)Ellen Bjurgert, VP of Investor RelationsLina Danstrup, Sr. Media Relations Mang. of Corp. Communications How do I buy shares of COLOPLAST A/S/ADR? Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is COLOPLAST A/S/ADR's stock price today? One share of CLPBY stock can currently be purchased for approximately $10.6050. What is COLOPLAST A/S/ADR's official website? The official website for COLOPLAST A/S/ADR is http://www.coloplast.com. How can I contact COLOPLAST A/S/ADR? COLOPLAST A/S/ADR's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The company can be reached via phone at 45-4911-1111 or via email at [email protected] MarketBeat Community Rating for COLOPLAST A/S/ADR (OTCMKTS CLPBY)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 99 (Vote Outperform)Underperform Votes: 103 (Vote Underperform)Total Votes: 202MarketBeat's community ratings are surveys of what our community members think about COLOPLAST A/S/ADR and other stocks. Vote "Outperform" if you believe CLPBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLPBY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Dividend Aristocrat Index Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.